The nomogram developed by Dr. Andrew Stephenson was
independently validated again, last year, by doctors at Loyola University. The "Stephenson nomogram" predicts the outcome of salvage radiation and is the basis for the
interactive tool on the Memorial Sloan Kettering Cancer Center (MSKCC) website.
The researchers followed men for a median of
71 months and found no significant difference between the outcomes for their patients and what the nomogram predicted. At a median time of 71 months,
46% were progression-free (that is, their PSA had not risen after salvage radiation.)
No comments:
Post a Comment